missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Zalutumumab Recombinant Human Monoclonal Antibody (2F8 (Zalutumumab; HuMax-EGFR))

Description
This antibody binds domain III of the human epidermal growth factor receptor (EGFR).
Zalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). Zalutumumab has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.
Specifications
Specifications
| Antigen | Zalutumumab |
| Applications | ELISA, Flow Cytometry, Western Blot |
| Classification | Recombinant Monoclonal |
| Clone | 2F8 (Zalutumumab; HuMax-EGFR) |
| Concentration | 1 mg/mL |
| Conjugate | Unconjugated |
| Formulation | PBS with 0.02% ProClin 300 |
| Gene Alias | HuMax-EGFr |
| Host Species | Human |
| Immunogen | The original monoclonal antibody was generated by immunizing HuMAb mice with alternating A431 cells and purified EGFR administration. |
| Show More |
Product Title
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?